Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells (Q64105309)

1

0 references

Min Zhou

2

0 references

Zeyan Pan

3

0 references

Ruixin Sun

4

0 references

Muhua Chen

5

0 references

Hua Jiang

6

0 references

Bizhi Shi

7

0 references

Hong Luo

8

0 references

Zonghai Li

Creative Commons Attribution 4.0 International

9

0 references

language of work or name

English

0 references

publication date

2019

0 references

published in

Frontiers in Oncology

0 references

volume

9

0 references

page(s)

241

0 references

copyright license

start time

17 April 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Toxicity of polyinosinic-polycytidylic acid admixed with poly-L-lysine and solubilized with carboxymethylcellulose in mice

1 reference

12 December 2020

Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

1 reference

12 December 2020

Toll-like receptor ligands directly promote activated CD4+ T cell survival

1 reference

12 December 2020

The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor

1 reference

12 December 2020

Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor.

1 reference

12 December 2020

Targeting the effector site with IFN-alphabeta-inducing TLR ligands reactivates tumor-resident CD8 T cell responses to eradicate established solid tumors

1 reference

12 December 2020

The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice

1 reference

12 December 2020

Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.

1 reference

12 December 2020

Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study

1 reference

12 December 2020

Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma

1 reference

12 December 2020

Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model

1 reference

12 December 2020

Anticancer function of polyinosinic-polycytidylic acid

1 reference

12 December 2020

Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors

1 reference

12 December 2020

History of myeloid-derived suppressor cells

1 reference

12 December 2020

Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.

1 reference

12 December 2020

Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer

1 reference

12 December 2020

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors

1 reference

12 December 2020

Combination cancer immunotherapies tailored to the tumour microenvironment

1 reference

12 December 2020

Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human.

1 reference

12 December 2020

Antitumour actions of interferons: implications for cancer therapy

1 reference

12 December 2020

Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

1 reference

12 December 2020

Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas

1 reference

12 December 2020

Double-stranded RNA promotes CTL-independent tumor cytolysis mediated by CD11b+Ly6G+ intratumor myeloid cells through the TICAM-1 signaling pathway

1 reference

12 December 2020

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

1 reference

12 December 2020

PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CAR.

1 reference

12 December 2020

Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment

1 reference

12 December 2020

Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers

1 reference

12 December 2020

A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy.

1 reference

12 December 2020

Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy

1 reference

12 December 2020

FDA approves first CAR T therapy.

1 reference

12 December 2020

FDA Approves Second CAR T-cell Therapy

1 reference

12 December 2020

Phase I Study of Chimeric Antigen Receptor Modified T Cells in Patients with EGFR-positive Advanced Biliary Tract Cancers

1 reference

12 December 2020

Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils.

1 reference

12 December 2020

NKG2D-based CAR-T cells and radiotherapy exert synergistic efficacy in glioblastoma.

1 reference

12 December 2020

Interferon regulatory factor 3 mediates Poly(I:C)-induced innate immune response and apoptosis in non‑small cell lung cancer.

1 reference

12 December 2020